Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» peanut allergy
peanut allergy
In another win for rival Aimmune, FDA presses pause on DBV's peanut patch with additional questions
Endpoints
Tue, 03/17/20 - 12:01 pm
FDA
Aimmune
DBV Technologies
peanut allergy
Viaskin Peanut
DBV's peanut prevention patch approaches key stage of approval process
Endpoints
Fri, 02/21/20 - 10:27 am
DBV Technologies
peanut allergy
FDA
drug approvals
Viaskin Peanut
What Aimmune's Peanut Allergy Drug Approval Means for the Rest of the Pipeline
Motley Fool
Wed, 02/5/20 - 10:14 am
Aimmune
FDA
peanut allergy
Palfozia
DBV Technologies
Aimmune wins approval for peanut immunotherapy, charges 10k+
Endpoints
Sat, 02/1/20 - 11:54 pm
Aimmune
Palforzia
peanut allergy
FDA
FDA decision nears on Aimmune's contested peanut allergy drug
BioPharma Dive
Fri, 01/24/20 - 12:07 pm
FDA
Aimmune
peanut allergy
Palforzia
DBV Technologies
Viaskin Peanut
Why the FDA's Decision on Aimmune's Peanut Allergy Drug Is Crucial for the Company -- and Patients
Motley Fool
Fri, 01/10/20 - 10:42 am
Aimmune Therapeutics
FDA
Palforzia
peanut allergy
patients
Stanford researchers pursue AnaptysBio's embattled IL-33 drug in peanut allergy
Fierce Biotech
Thu, 11/14/19 - 10:23 am
Stanford University
AnaptysBio
peanut allergy
etokimab
Aimmune Presents New Peanut Allergy Data and Presses for Real-World Data Approaches
BioSpace
Sat, 11/9/19 - 12:07 pm
Aimmune Therapeutics
peanut allergy
AR101
real world data
RWE
DBV Technologies announces FDA acceptance of BLA filing for Viaskin Peanut to treat peanut allergy
Pharmaceutical Business Review
Mon, 10/7/19 - 10:58 am
Viaskin Peanut
DBV Technologies
FDA
peanut allergy
Allergists Debate Anticipated FDA Approval Of A Peanut Allergy Drug
NPR
Mon, 09/23/19 - 07:30 pm
Aimmune Therapeutics
peanut allergy
Palforzia
Aimmune's peanut allergy drug secures FDA panel support, along with criticism
Biopharma Dive
Fri, 09/13/19 - 07:05 pm
Aimmune
FDA
peanut allergy
advisory panel
Palforzia
AR 101
An FDA advisory panel is reviewing Aimmune’s peanut allergy therapy. Here’s what’s happening
Stat
Fri, 09/13/19 - 10:18 am
FDA
advisory panels
peanut allergy
Aimmune Therapeutics
Palforzia
No surprises in FDA staff review for Aimmune peanut allergy therapy — focus remains on safety, tolerability profile
Endpoints
Wed, 09/11/19 - 10:27 am
Aimmune
FDA
peanut allergy
Palforzia
AR101
DBV Technologies Resubmits BLA for Peanut Allergy Treatment
BioSpace
Thu, 08/8/19 - 11:52 pm
DBV Technologies
FDA
peanut allergy
Viaskin Peanut
New peanut allergy therapies aren’t as effective — or nearly as inexpensive — as abstinence, says ICER
Endpoints
Thu, 07/11/19 - 12:03 pm
peanut allergy
Aimmune Therapeutics
DBV Technologies
ICER
AR101
Viaskin Peanut
Vedanta Biosciences enrolls first patient in VE416 phase 1b/2 food allergy clinical study
Pharmaceutical Business Review
Tue, 07/2/19 - 11:46 am
Vedanta Biosciences
clinical trials
peanut allergy
VE416
FDA schedules Aimmune's peanut allergy drug for September expert review
Biopharma Dive
Thu, 05/16/19 - 12:01 pm
Aimmune Therapeutics
peanut allergy
FDA
AR101
Aimmune's peanut allergy immunotherapy clears European PhIII with flying colors, paving way for first US, EU therapeutic approval
Endpoints
Mon, 03/25/19 - 12:03 pm
Aimmune
peanut allergy
Europe
EMA
FDA
AR-101
4 Blockbuster Drug Launches to Watch in 2019
Motley Fool
Sun, 03/24/19 - 08:08 pm
drug launches
AbbVie
Alexion Pharmaceuticals
Aimmune Therapeutics
Skyrizi
psoriasis
Upadacitinib
rheumatoid arthritis
Ultomiris
PNH
AR101
peanut allergy
Aimmune has its answer on peanut drug's status, but how FDA proceeds still unclear
BioSpace
Fri, 03/1/19 - 08:30 pm
Aimmune Therapeutics
peanut allergy
FDA
AR101
Pages
« first
‹ previous
1
2
3
next ›
last »